Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Iclusig Recall Issued Due to Risk of Blood Clots, Blood Vessel Narrowing November 4, 2013 Irvin Jackson Add Your Comments Due to the risk of severe and potentially life-threatening blood clots from side effects of Iclusig, Ariad Pharmaceuticals has agreed to suspend sales of the recently introduced leukemia drug. On October 31, the FDA updated a drug safety communication to announce that the agency asked Ariad to remove Iclusig from the market amid reports of blood clots and severe narrowing of blood vessels. The agency first issued a warning about the potential Iclusig risks on October 11, announcing that the FDA was investigating an increasing frequency of adverse event reports since the medication was approved in December 2012. As a result of the blood clot problems, Ariad also halted clinical trials due to the potential risks test subjects faced. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Iclusig (ponatinib) was approved less than a year ago for treatment of chronic phase, accelerated phase, or blast phase chronic myeloid leukemia or Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia. It is reserved for patients who no longer benefit from or tolerate other treatments. When the drug was first put on the market, it was known that Iclusig increased the risk of blood clots, but it appears the level of that risk is much higher than the FDA was originally told. The original clinical trial data Ariad gave to the FDA showed the development of blood clots in 8% of Iclusing users. However, once the drug was on sale to the public, clinical trial data indicated that 24% of Iclusig users studied over a median of 1.3 years suffered serious adverse vascular events. That number jumped to 48%, nearly half, when the median was 2.7 years of use. According to the FDA, data from the clinical trials showed patients suffered heart attacks, death, worsening coronary artery disease, stroke, restricted arteries of the brain and blood vessels in the extremities and the “need for urgent surgical procedures to restore blood flow.” Other problems the FDA reports that patients have experienced include congestive heart failure and tissue death requiring amputation. There have also been reports of vision loss and clots of blood vessels in the eye. The suspension may not result in a permanent Iclusig recall, as FDA officials are continuing to study the medication to better understand the risks of the drug and to determine if there are patient populations for whom the benefits outweigh the risks. The agency advises patients to discuss whether they should continue to use the drug with their doctors. The FDA warns that patients taking Iclusig should seek immediate medical attention if they experience symptoms like those of a heart attack or stroke, including: Chest pain or pressure Pain in the arms, back neck or jaw Shortness of breath Numbness or weakness on one side of the body Trouble talking Severe headache Dizziness Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Blood Clot, Cancer, Heart Attack, Iclusig, Leukemia, Stroke Image Credit: | More Lawsuit Stories Link Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate September 22, 2025 Two Uber Sexual Assault Bellwether Trials To Be Held in North Carolina September 22, 2025 Pressure Cooker Burn Injury Lawsuit Filed Over Defective Safety Features September 22, 2025 0 Comments NameThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Link Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate (Posted: today) Plaintiffs involved in Depo-Provera intracranial meningioma lawsuits are pushing back against Pfizer’s claim that the complaints are preempted by federal law. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Symptoms Create Lifelong Meningioma Fears Among Women (09/17/2025)Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (09/03/2025)Pfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025) Ozempic Bowel Obstruction Caused Severe, Permanent Injuries: Lawsuit (Posted: 3 days ago) An Ozempic lawsuit claims a Wisconsin woman suffered small bowel obstruction and gastroparesis after using the popular diabetes and weight loss drug. MORE ABOUT: OZEMPIC LAWSUITWoman Files Trulicity and Ozempic Lawsuit Over Ileus, Intestinal Obstruction (09/05/2025)Weight Loss Surgery May Increase Kidney Injury Risks: Study (09/04/2025)GLP-1 Side Effects May Increase Kidney Cancer Risks: Study (09/03/2025) States Move To Ban Nitrous Oxide ‘Whippet’ Sales Amid Rising Youth Addiction and Deaths (Posted: 3 days ago) As states move to ban nitrous oxide canisters amid rising teen addictions and injuries, government crackdowns may bolster lawsuits claiming companies ignored warning signs. MORE ABOUT: NITROUS OXIDE LAWSUITGalaxy Gas Indicates Class Action Lawsuits Over Nitrous Oxide Canisters Should Be in Same Court (09/10/2025)Nitrous Oxide Nerve Damage Lawsuits Highlight Experts’ Warnings About Irreversible Spinal Cord Injuries (08/18/2025)Insurer Denies Coverage for Lawsuit Over Nitrous Oxide Canister Sales (08/11/2025)
Link Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate September 22, 2025
Link Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate (Posted: today) Plaintiffs involved in Depo-Provera intracranial meningioma lawsuits are pushing back against Pfizer’s claim that the complaints are preempted by federal law. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Symptoms Create Lifelong Meningioma Fears Among Women (09/17/2025)Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (09/03/2025)Pfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)
Ozempic Bowel Obstruction Caused Severe, Permanent Injuries: Lawsuit (Posted: 3 days ago) An Ozempic lawsuit claims a Wisconsin woman suffered small bowel obstruction and gastroparesis after using the popular diabetes and weight loss drug. MORE ABOUT: OZEMPIC LAWSUITWoman Files Trulicity and Ozempic Lawsuit Over Ileus, Intestinal Obstruction (09/05/2025)Weight Loss Surgery May Increase Kidney Injury Risks: Study (09/04/2025)GLP-1 Side Effects May Increase Kidney Cancer Risks: Study (09/03/2025)
States Move To Ban Nitrous Oxide ‘Whippet’ Sales Amid Rising Youth Addiction and Deaths (Posted: 3 days ago) As states move to ban nitrous oxide canisters amid rising teen addictions and injuries, government crackdowns may bolster lawsuits claiming companies ignored warning signs. MORE ABOUT: NITROUS OXIDE LAWSUITGalaxy Gas Indicates Class Action Lawsuits Over Nitrous Oxide Canisters Should Be in Same Court (09/10/2025)Nitrous Oxide Nerve Damage Lawsuits Highlight Experts’ Warnings About Irreversible Spinal Cord Injuries (08/18/2025)Insurer Denies Coverage for Lawsuit Over Nitrous Oxide Canister Sales (08/11/2025)